These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 15016861

  • 1. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
    Peletskaya EN, Kogon AA, Tuske S, Arnold E, Hughes SH.
    J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Substitution of conserved hydrophobic residues in motifs B and C of HIV-1 RT alters the geometry of its catalytic pocket.
    Sharma B, Kaushik N, Singh K, Kumar S, Pandey VN.
    Biochemistry; 2002 Dec 31; 41(52):15685-97. PubMed ID: 12501197
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E, El Dirani-Diab R, Boulmé F, Fournier M, Nevinsky G, Tarrago-Litvak L, Litvak S, Andreola ML.
    Eur J Biochem; 1998 Jan 15; 251(1-2):487-95. PubMed ID: 9492322
    [Abstract] [Full Text] [Related]

  • 8. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.
    Das K, Ding J, Hsiou Y, Clark AD, Moereels H, Koymans L, Andries K, Pauwels R, Janssen PA, Boyer PL, Clark P, Smith RH, Kroeger Smith MB, Michejda CJ, Hughes SH, Arnold E.
    J Mol Biol; 1996 Dec 20; 264(5):1085-100. PubMed ID: 9000632
    [Abstract] [Full Text] [Related]

  • 9. Structure of HIV-1 reverse transcriptase/d4TTP complex: Novel DNA cross-linking site and pH-dependent conformational changes.
    Martinez SE, Bauman JD, Das K, Arnold E.
    Protein Sci; 2019 Mar 20; 28(3):587-597. PubMed ID: 30499174
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the beta3-beta4 hairpin loop in dNTP selection.
    Garforth SJ, Kim TW, Parniak MA, Kool ET, Prasad VR.
    J Mol Biol; 2007 Jan 05; 365(1):38-49. PubMed ID: 17055529
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms.
    Hsiou Y, Ding J, Das K, Clark AD, Hughes SH, Arnold E.
    Structure; 1996 Jul 15; 4(7):853-60. PubMed ID: 8805568
    [Abstract] [Full Text] [Related]

  • 16. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
    Gao HQ, Boyer PL, Sarafianos SG, Arnold E, Hughes SH.
    J Mol Biol; 2000 Jul 07; 300(2):403-18. PubMed ID: 10873473
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
    Das K, Sarafianos SG, Clark AD, Boyer PL, Hughes SH, Arnold E.
    J Mol Biol; 2007 Jan 05; 365(1):77-89. PubMed ID: 17056061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.